CompletedNot Applicable

Squishy Toy and Palpation in Pediatric IV Success

Turkey (Türkiye)90 participantsStarted 2024-12-01

Plain-language summary

This randomized controlled trial investigates the effects of two non-pharmacological techniques-squishy toy squeezing and vein palpation-on the success rate of peripheral intravenous catheter (PIVC) insertion in pediatric hematology and oncology patients. Data collection takes place in the procedure room of a pediatric outpatient clinic. The study includes children who have a Difficult Intravenous Access (DIVA) score of 4 or higher, indicating difficult venous access. Participants are randomly assigned to one of three groups: the squishy toy group, the palpation group, or the control group, which receives standard care. In the squishy toy group, children use soft, elastic toys to activate hand muscles and improve blood flow, aiming to enhance vein visibility. In the palpation group, the target vein is gently tapped to increase local blood circulation and make the vein more prominent. The control group undergoes catheter insertion without any additional stimulation techniques. All data are recorded using structured forms that collect demographic, clinical, and procedural information. The study aims to determine whether these simple and cost-effective interventions improve the success rate of PIVC insertion in children with difficult venous access.

Who can participate

Age range

7 Years – 17 Years

Sex

ALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * Children identified by the healthcare team as needing peripheral intravenous catheter placement who also have a Difficult Intravenous Access (DIVA) score of 4 or above. Exclusion Criteria: * Children unable to squeeze a toy due to physical limitations were excluded from the study.

Questions worth asking your doctor

Bring these to your next appointment. They're a starting point for a shared conversation — not a sign you qualify or a recommendation to enrol.

1Based on my diagnosis and history, is this trial worth exploring for me — or is there a standard treatment we should try first?
2What does this trial's phase tell us about how much is already known about its safety and benefit?
3What would taking part actually involve for me — visits, tests, time, and travel?
4What are the known and possible risks or side effects I should weigh, and how would they be monitored?
5If this trial isn't the right fit, what other options or trials would you suggest I look into?

Generated to help you prepare — always confirm anything about your own eligibility and care with the study team and your doctor.

Questions for the trial coordinator

The trial coordinator is the person who runs the study day to day. These cover the practical side — logistics, costs, and what taking part would actually mean for your life. The study team confirms whether you meet the criteria; these are questions to ask, not a sign you qualify.

1What does taking part actually involve week to week — how many visits, where, and how long does each one take?
2What costs are covered by the study, and what might I have to pay for myself, including travel, parking, or time off work?
3What happens during screening, and what happens if the study team confirms I don't meet the criteria after those tests?
4Who pays for the scans, blood work, and other tests the trial requires — the study, my insurance, or me?
5How will being in the trial affect my regular care, and will my own doctor stay informed and involved?
6Can I leave the trial at any point if I change my mind, and what would happen to my care if I do?

A starting point for the conversation — always confirm anything about your own eligibility, costs, and care with the study team and your doctor.

What they're measuring

Number of IV attempts to successful acces

Timeframe: During the procedure

Time to successful acces

Timeframe: During the procedure

Trial details

NCT IDNCT07041216

SponsorAkdeniz University

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2025-07-31

View on ClinicalTrials.gov More Pediatric ALL trials